Can a valve fix unlock better heart failure drugs?

NCT ID NCT07758023

Not yet recruiting Disease control Sponsor: University Medical Center Mainz Source: ClinicalTrials.gov ↗

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial tests whether repairing a leaky mitral valve early, using a minimally invasive clip procedure, can help people with heart failure and reduced pumping function tolerate and benefit from standard heart failure medications. Participants are randomly assigned to receive the valve repair plus a structured medication plan, or the medication plan alone. The study measures how well medications are optimized, quality of life, and long-term outcomes like hospitalizations and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transcatheter edge-to-edge repair (M-TEER) of the mitral valve, plus a standardized regimen of heart failure medications
What this could lead to: If successful, this approach could help heart failure patients get on full, life-saving medications faster and improve their quality of life and survival.
What could go wrong: The procedure carries risks, and it's unclear if early valve repair will truly enable better medication tolerance or improve long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mitral valve insufficiency systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) MITRAL REGURGITATION FUNCTIONAL

More trials for these conditions

Other studies related to the condition(s) this trial covers.